Digital Therapeutics (DTx) Applications Quadrant Report

Table of Contents

1 Introduction
   1.1 Market Definition

2 Market Overview
   2.1 Market Dynamics
          Figure 1 Digital Therapeutics Market: Drivers, Restraints, Opportunities, and Challenges
          2.1.1 Drivers
                    2.1.1.1 Increasing Incidence of Preventable Chronic Diseases
                    2.1.1.2 Rising Focus on Preventive Healthcare
                    2.1.1.3 Need to Control Healthcare Costs
                    2.1.1.4 Significant Increase in Venture Capital Investments
                    2.1.1.5 Benefits of Digital Therapeutics
                                 2.1.1.5.1 Ability to Induce Behavioral Change
                                 2.1.1.5.2 Improved Drug Adherence
                                 2.1.1.5.3 Patient Convenience and User-Friendliness
          2.1.2 Restraints
                    2.1.2.1 Patient Data Privacy Concerns
          2.1.3 Opportunities
                    2.1.3.1 Emerging Markets
                    2.1.3.2 Large Undiagnosed and Untreated Population
                    2.1.3.3 Unexplored Therapeutic Applications
          2.1.4 Challenges
                    2.1.4.1 Unstable Payment Models
                    2.1.4.2 Reluctance Among Patients to Adopt Digital Therapeutics
                    2.1.4.3 Lack of Awareness and Access to Digital Therapeutics Programs in Developing Countries
                    2.1.4.4 Resistance From Traditional Healthcare Providers

3 Company Evaluation Quadrant
   3.1 Visionary Leaders
   3.2 Dynamic Differentiators
   3.3 Innovators
   3.4 Emerging Companies
          Figure 2 Digital Therapeutics (DTx) Market (Global) Company Evaluation Quadrant

4 Competitive Landscape
   4.1 Overview
          Figure 3 Key Developments in the Digital Therapeutics Market
   4.2 Market Ranking Analysis, 2019
          Figure 4 Digital Therapeutics Market Ranking Analysis, 2019
   4.3 Competitive Situation and Trends
          4.3.1 Product Launches
          4.3.2 Expansions
          4.3.3 Partnerships, Agreements, and Collaborations

5 Company Profiles
   5.1 Noom
          5.1.1 Business Overview*
          5.1.2 Products Offered*
          5.1.3 Recent Developments*
          5.1.4 MnM View*
         (*Above sections are present for all of below companies)
   5.2 Livongo Health
   5.3 Omada Health
   5.4 Cognifit
   5.5 Proteus Digital Health
   5.6 WellDoc
   5.7 Ginger
   5.8 Propeller Health
   5.9 2Morrow
   5.10 Canary Health
   5.11 Mango Health Inc.
   5.12 Click Therapeutics
   5.13 Pear Therapeutics
   5.14 Akili Interactive Labs
   5.15 Wellthy Therapeutics
   5.16 Cognoa
   5.17 Happify
   5.18 Kaia Health
   5.19 Ayogo Health
   5.20 Better Therapeutics
   5.21 Mindstrong Health

6 Appendix
   6.1 Methodology

This report identifies and benchmarks key market players in the digital therapeutics market such as Noom (US), Livongo Health (US), and Omada Health (US), and evaluates them on the basis of business strategy excellence and strength of product portfolio within the Digital Therapeutics ecosystem, combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. They are rated and positioned on 2x2 matrix, called as ‘Company Evaluation Quadrant’, and identified as Visionary Leaders, Dynamic Differentiators, Innovators, or Emerging companies.

SAMPLES: